We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
Bibliografía
1
1Sachdev, P. The development of the concept of akathisia: a historical overview.Schizophr Res1995;l6(1):33–45.CrossRefGoogle Scholar
2
2Walters, AS, Hening, W. Rubinstein, M, et al. A clinical and polysomnography comparison of neuroleptic-induced akathisia and the idiopathic restless legs syndrome.Sleep1991;14(4):339-45.Google Scholar
3
3Lai, S, Nair, NP. Is levomepromazine a useful drug in treatmentresistant schizophrenia?Acta Psychiatr Scand1992;85(3):243-5.Google Scholar
4
4Blaisdell, GD. Akathisia: a comprehensive review and treatment summary.Pharmacopsychiatry1994;27(4):139-46.CrossRefGoogle ScholarPubMed
5
5Miller, CH, Mohr, F, Umbricht, D, et al. The prevalence of acute extrapyramidal signs and symptoms in patients treated with clozapine, risperidone, and conventional antipsychotics.J Clin Psychiatry1998;59(2):69–75.CrossRefGoogle ScholarPubMed
6
6Meltzer, HY. The role of serotonin in antipsychotic drug action.Neuropsychopharmacology1999;21 (2 Suppl):106S-15S.CrossRefGoogle ScholarPubMed
7
7Lai, S, Nair, NP, Cecyre, D, et al. Levomepromazine receptor binding profile in human brain-implications for treatmentresistant schizophrenia.Acta Psychiatr Scand1993;87(6):380-3.Google Scholar